I am so excited by those biosecurity-oriented ideas!
I had a few thoughts about the Advocacy for funding R&D into new antimicrobials:
The current financial incentives to drive new drug development to address this are insufficient. The pipeline is broken; only a handful of novel antibiotics have been developed in the last 30 years. This new charity will advocate for these better market mechanisms, to incentivise the creation and the responsible deployment and use of important new antimicrobial drugs.
I am curious why phage therapy is not mentioned there. Is that intentional? Would it be because it might be much harder to get regulatory approval for this kind of therapy? Or for simplicity of the summary?
Thanks in advance for your answer!
Thank you so much for this, it's so helpful! It looks like an extensive library of useful links too.
I have a few questions:
Thanks again!
Hi, my name is Alix.
I graduated from ETH Zürich and Ecole Polytechnique (France) with a Biomedical Engineering MSc in 2021. I am currently pursuing a Ph.D. focused on the gut microbiota: I am not actively looking for a job, but would very much like to find something much more impactful than what I am doing right now.
Hello! I couldn't join for the original program, will you run it again? I would be very happy to join, if so.
Thanks for making this possible!